ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET

Group 1 - ANI Pharmaceuticals, Inc. will release its fourth quarter and full year 2025 financial results on February 27, 2026, prior to market opening [1] - A conference call will be hosted by key executives including the CEO and CFO to discuss the financial results [1] - The conference call is scheduled for 8:00 a.m. ET and will be accessible via toll-free number and webcast [1] Group 2 - ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics [2] - The company aims for sustainable growth through its Rare Disease business, which includes products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology [2] - ANI also operates a Generics business leveraging R&D expertise and U.S.-based manufacturing [2]